Detection of antibacterial activity in spent roots of two genotypes of aromatic grass Vetiveria zizanioides

Pharmaceutical Biology

Volumn 43, Issue 8, 2005, Pages 732-736

  Luqman, Suaib ^a   Srivastava, Suchi ^a   Darokar, Mahendra P ^a   Khanuja, Suman P S ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Disk diffusion; Escherichia coli; MIC; Mycobacterium smegmatis; Vetiveria zizanioides

Indexed keywords

PLANT EXTRACT; UNCLASSIFIED DRUG; VETIVERIA ZIZANIOIDES EXTRACT;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; GENOTYPE; INFLORESCENCE; MEDICINAL PLANT; MYCOBACTERIUM SMEGMATIS; NONHUMAN; VETIVERIA ZIZANIOIDES;

ESCHERICHIA COLI; MYCOBACTERIUM SMEGMATIS; VETIVERIA ZIZANIOIDES;

EID: 30344470750     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200500387471     Document Type: Article

References (25)

1. Bauer AW, Kirby WMM, Sherries JC, Turck M (1966): Antibiotic sensitivity testing by a standardised single disk method. Am J Clin Pathol 45: 493-496.
2. Blanchard JS (1996): Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 65: 215-239.
3. Brown EM, Reeves DS (1997): Quinolones. In: O'Grady F, Lambert HP, Finch RG, Greenwood D, eds., Antibiotics and Chemotherapy, 7th ed. Edinburgh, Churchill Livingstone, pp. 419-452.
4. Gangrade SK, Shrivastava RD, Sharma OP, Jain NK, Trivedi KC (1991): In vitro antifungal effect of the essential oils. Indian Perfumer 35: 46-48.
5. Gangrade SK, Shrivastava RD, Sharma OP, Moghe MN, Trivedi KC (1990): Evaluation of some essential oils for antibacterial properties. Indian Perfumer 34: 204-208.
6. Greenwood D (1997): Historical introduction. In: O'Grady F, Lambert HP, Finch RG, Greenwood D, eds., Antibiotics and Chemotherapy, 7th ed. Edinburgh, Churchill Livingstone, pp. 2-9.
7. Hammer KA, Carson CF, Riley TV (1999): Antimicrobial activity of essential oils and other plant extracts. J App Microbiol 86: 985-990.
8. Jagtap AG, Shirke SS (2002): Effect of polyherbal formulations on experimental models for inflammatory bowel disease. Indian J Pharmacol 34: 296-299.
9. Jain SK (1991): Dictionary of Indian Folk Medicine and Ethnobotany. New Delhi, Deep Publication, pp. 193-223.
10. Jain SC, Nowicki S, Eisner T, Meinwald J (1982): Insect repellents from vetiver oil: Zizanal and epizizanal. Tetrahedron Lett 23: 4639-4642.
11. Jorgensson JH, Turnigde DJ, Washington JA (1999): Antibacterial susceptibility tests: Dilution and disc diffusion methods. In: Murray PR, Barone EJ, P Faller MA, Tenover FC, Yolken RH, eds., Manual of Clinical Microbiology, 7th ed. Washington, DC, The American Society of Microbiology Press, pp. 1526-1543.
12. Kumar S (1976): Properties of adenyl cyclase and cyclic adenosine 3′-5′ monophosphate receptor protein deficient mutants of Escherichia coli. J Bacteriol 125: 545-555.
13. Nathan C (2004): Antibiotics at the cross roads. Nature 431: 899-902.
14. Pan X-S, Ambler J, Mehtar S, Fisher ML (1996): Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 40: 2321-2326.
15. Pandey KK, Vandana, Dwivedi M (2001): Urinary tract infection and its management by Renalka. Antiseptic 98: 295-296.
16. Projan SJ (2003): Why is Big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6: 427-430.
17. Rao RR, Suseela MR (2000): Vetiveria zizaniodes (Linn.) Nash. A multipurpose ecofriendly grass of India. Proceedings of Second International Conference on Vetiver. Office of the Royal Development Projects Board, Bangkok, pp. 444-448.
18. Santha Kumar TR, Khanuja SPS, Jain DC, Bhattacharya AK, Sharma RP, Kumar S (2000): A simple microbiological assay for the stereospecific differentiation of α and β isomers of arteether. Phytother Res 14: 644-646.
19. Sinha P (2003): Isolating plant derived antimycobacterial compounds through construction of novel target based bioscreens. Ph.D. Thesis, Barkatullah University, Bhopal, India.
20. Singh M (2004): Isolation and characterisation of multi drug resistant mutants in Mycobacterium smegmatis. M.Sc. Thesis, Barkatullah University, Bhopal, India.
21. Singh KK, Maheswari JK (1983): Traditional phytotherapy amongst the tribals of Varanasi district U.P. J Econ Tax Bot 4: 829-838.
22. Snapper SB, Lugosi L, Jekkel A, Melton RE, Kieser T, Bloom BR, Jacobs WR (1988): Lysogeny and transformation in Mycobacteria: Stable expression of foreign genes. Proc Natl Acad Sci USA 85: 6987-6991.
23. Srivastava S (2002): Bioprospecting potent plant compounds targeted to inhibit cell wall synthesis and DNA replication in Mycobacterium smegmatis. Ph.D. Thesis, Devi Ahilya Vishwavidyalaya, Indore, India.
24. Watt B (1997): In vitro sensitivities and treatment of less common mycobacteria. J Antimicrob Chemother 39: 567-574.
25. Wenzel RP (2004): The antibiotic pipeline-challenges, costs and values. N Engl J Med 351: 523-526.